Literature DB >> 17050072

The effect of specimen hemolysis on coagulation test results.

Alvaro C Laga1, Tracey A Cheves, Joseph D Sweeney.   

Abstract

Hemolyzed specimens are rejected for coagulation testing based on concerns of artifactual interference. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and selected factor assay test results for consecutive pairs of hemolyzed and subsequently recollected (mean, 72 minutes later) nonhemolyzed patient specimens were compared. Specimens from healthy human subjects were subjected to mechanically induced hemolysis, and PT and aPTT results compared with concurrently drawn nonhemolyzed control samples. In 50 paired patient specimens, there were statistically significant differences in PT (15.8 +/- 8.4 vs 16.3 +/- 8.7 seconds, P < .01) and aPTT (31.6 +/- 18 vs 32.5 +/- 19 seconds, P < .01) between hemolyzed and nonhemolyzed specimens, respectively. Specimens from healthy subjects showed no difference in PT and a minor difference in aPTT. A policy of rejecting hemolyzed specimens for coagulation tests should be revisited because the observed difference, when present, is unlikely to be considered clinically meaningful.

Entities:  

Mesh:

Year:  2006        PMID: 17050072     DOI: 10.1309/03FK-3378-YTRA-1FRF

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Effectiveness of practices to reduce blood sample hemolysis in EDs: a laboratory medicine best practices systematic review and meta-analysis.

Authors:  Nicholas J Heyer; James H Derzon; Linda Winges; Colleen Shaw; Diana Mass; Susan R Snyder; Paul Epner; James H Nichols; Julie A Gayken; Dennis Ernst; Edward B Liebow
Journal:  Clin Biochem       Date:  2012-09       Impact factor: 3.281

2.  A retrospective analysis of the incidence of hemolysis in type and screen specimens from trauma patients.

Authors:  Kavin G Shah; Juan P Idrovo; Jeffrey Nicastro; Heather F McMullen; Ernesto P Molmenti; Gene Coppa
Journal:  Int J Angiol       Date:  2009

3.  Quantitative assessment of prevalence of pre-analytical variables and their effect on coagulation assay. Can intervention improve patient safety?

Authors:  Ravi Bhushan; Arijit Sen
Journal:  Med J Armed Forces India       Date:  2017-01-05

4.  Hemolyzed Samples Should be Processed for Coagulation Studies: The Study of Hemolysis Effects on Coagulation Parameters.

Authors:  S Arora; S Kolte; Js Dhupia
Journal:  Ann Med Health Sci Res       Date:  2014-03

5.  Red Blood Cells are Appropriate Carrier for Coagulation Factor VIII.

Authors:  Fatemeh Sayyadipour; Naser Amirizadeh; Arezoo Oodi; Masoud Khalili; Fakhredin Saba
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2020

6.  A collaborative study by the Working Group on Hemostasis and Thrombosis of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) on the interference of haemolysis on five routine blood coagulation tests by evaluation of 269 paired haemolysed/non-haemolysed samples.

Authors:  Chiara Novelli; Matteo Vidali; Bruno Brando; Benedetto Morelli; Giovanna Andreani; Marina Arini; Paola Calzoni; Roberta Giacomello; Barbara Montaruli; Emanuela Muccini; Angela Papa; Paola Pradella; Lucia Ruocco; Fosca Siviero; Filomena Gemma Viola; Mario Zanchetta; Lorena Zardo; Giuseppe Lippi
Journal:  Biochem Med (Zagreb)       Date:  2018-10-15       Impact factor: 2.313

7.  Differential impacts of hemolysis on coagulation parameters of blood samples: A STROBE-compliant article.

Authors:  Lin-Lin Pan; Ching-Hui Lee; Kuo-Chuan Hung; I-Ting Tsai; Ming-Chung Wang; Cheuk-Kwan Sun
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.